# A Post Marking Study to Evaluate the Safety of FluMist in Children

> **NCT00569894** · — · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 29296 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** FLuMist
- **BIOLOGICAL:** TIV (Injection)
- **OTHER:** Unvaccinated Control

## Key facts

- **NCT ID:** NCT00569894
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 29296 (ACTUAL)
- **Last updated:** 2012-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569894, "A Post Marking Study to Evaluate the Safety of FluMist in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00569894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*